← FDA Drug Approvals (Drugs@FDA)
TRIAMTERENE AND HYDROCHLOROTHIAZIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ · Approved 1997-06-05
Drug application
- FDA Application #
ANDA074821- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TRIAMTERENE AND HYDROCHLOROTHIAZIDE
- Generic name
- TRIAMTERENE AND HYDROCHLOROTHIAZIDE
- Active ingredients
- HYDROCHLOROTHIAZIDE; TRIAMTERENE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SANDOZ
- Manufacturer
- Sandoz Inc
- First approval
- 1997-06-05
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown